Mupirocin resistance among Iranian isolates of Staphylococcus aureus

Medical Science Monitor

Volumn 14, Issue 10, 2008, Pages

  Saderi, Horieh ^a   Owlia, Parviz ^a   Habibi, Mehri ^a  

^a SHAHED UNIVERSITY   (Iran)

Author keywords

Antimicrobial susceptibility; Iran; Mupirocin resistance; Staphylococcus aureus

Indexed keywords

CEFOXITIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GENTAMICIN; LINEZOLID; OXACILLIN; PENICILLIN G; PSEUDOMONIC ACID; RIFAMPICIN; SULTAMICILLIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DISK DIFFUSION; IRAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STAPHYLOCOCCUS AUREUS;

ADULT; AGED; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; IRAN; MALE; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MUPIROCIN;

EID: 54249163083     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Deshpande LM, Fix AM, Pfaller MA: Emerging elevated mupirocin resistance rates among staphylococcal isolates in the SENTRY Antimicrobial Surveillance Program (2000): correlations of results from disk diffusion, E-test and reference dilution methods. Diagn Microbiol Infect Dis, 2000; 42: 283-90
2. Petinaki E, Spiliopoulou I, Kontos F et al: Clonal dissemination of mupirocin-resistant staphylococci in Greek hospitals. J Antimicrob Chemother, 2004; 53: 105-8
3. Upton A, Lang S, Heffernan H: Mupirocin and Staphylococcus aureus: a recent paradigm of emerging antibiotic resistance. J Antimicrob Chemother, 2003; 51: 613-17
4. Udo EE, Jacob LE, Mathew B: The spread of a mupirocin-resistant/ methicillin-resistant Staphylococcus aureus clone in Kuwait hospitals. Acta Trop, 2001; 80: 155-61
5. Casewell MW, Hill RLR: In vitro activity of mupirocin (pseudomonic acid) against clinical isolates of Staphylococcus aureus. J Antimicrob Chemother, 1985; 15: 523-31
6. Gaspar MC, Sanchez P, Uribe P et al: Mupirocin susceptibility in vitro and nasal eradication of epidemic methicillin-resistant Staphylococcus aureus. J Hosp Infect, 1993; 24: 237-38
7. Gilbart J, Perry CR, Slocombe B: High-level mupirocin resistance in Staphylococcus aureus: evidence for two distinct isoleucyl-tRNA synthetases. Antimicrob Agents Chemother, 1993; 37: 32-38
8. Rahman M, Noble WC, Cookson BD: Transmissible mupirocin resistance in Staphylococcus aureus. Epidemiol Infect, 1989; 102: 261-70
9. Leski TA, Gniadkowski M, Skocczynska A et al: Outbreak of mupirocin-resistant staphylococci in a hospital in Warsaw, Poland, due to plasmid transmission and clonal spread of several strains. J Clin Microb, 1999; 37: 2781-88
10. th ed, Wayne, PA, 2005
11. Finlay JE, Miller LA, Poupard JA: Interpretive criteria for testing susceptibility of staphylococci to mupirocin. Antimicrob Agent Chemother, 1997; 41: 1137-39
12. Cookson BD, Lacey RW, Noble WC et al: Mupirocin-resistant Staphylococcus aureus. Lancet, 1990; 335: 1095-96
13. Rohani MY, Zainuldin MY, Koay AS, Lau MG: Antibiotic resistance patterns of bacteria isolated in Malaysian hospitals. Int Med J, 1999; 6: 47-51
14. Gadeppalli R, Dhawan B, Mohanty S et al: Mupirocin resistance in Staphylococcus aureus in an Indian hospital. Diag Microb Infect Dis, 2007; 58: 125-27
15. Maniatis N, Agel A, Legakis NJ, Tzouvelekis LS: Mupirocin resistance in Staphylococcus aureus from Greek hospitals. International J Antimicrob Agents, 2001; 18: 407-8
16. Yun HJ, Lee SW, Yoon GM et al: Prevalence and mechanisms of low- and high-level mupirocin resistance in staphylococci isolated from a Korean hospital. J Antimicrobial Chemother, 2003; 51: 619-23
17. Fujimura S, Watanabe A: Survey of high- and low-level mupirocin- resistant strains of methicillin-resistant Staphylococcus aureus in 15 Japanese hospitals. Chemotherapy, 2003; 49: 36-38
18. Schmitz FJ, Lindenlauf E, Hofmann B et al: The prevalence of low- and high-level mupirocin resistance in staphylococci from 19 European hospitals. J Antimicrob Chemother, 1998; 42: 489-95
19. Miller MA, Dascal A, Portnoy J, Mendelson J: Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemiol, 1996; 17: 811-13
20. Dawson SJ, Finn LF, McCulloch JE et al: Mupirocin-resistant MRSA. J Hosp Infect, 1994; 28: 79-80
21. Cookson BD: The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice. J Antimicrob Chemother, 1998; 41: 11-18
22. Norazah A, Koh YT, Kamel A et al: Mupirocin resistance among Malaysian isolates of methicillin-resistant Staphylococcus aureus. Int J Antimicrob Agents, 2001; 17: 411-14
23. Palepou MFI, Johnson AP, Cookson BD et al: Evaluation of disc diffusion and Etest for determining the susceptibility of Staphylococcus aureus to mupirocin. J Antimicrobial Chemother, 1998; 42: 577-83
24. Udo EE, Farook VS, Mokadas EM et al: Molecular finger printing of mupirocin-resistant methicillin-resistant Staphylococcus aureus from a burns unit. Int J Infect Dis, 1999; 3: 82-87
25. Kurlenda J, Grinholc M, Jasek K, Wegrzyn G: Rapt typing of methicillin-resistant Staphylococcus aureus: A 7-year experience in a Polish hospital. Med Sci Monit, 2007; 13(6): MT13-18